NR1H4 and irritable bowel syndrome: Recent researches have shown that FXR mRNA had higher expression levels in the rectosigmoid mucosa of IBS-D patients [85, 86], while Horikawa et al. [87] found it was also obviously increased in IBS patient's ileum, but not in the rectum, duodenum, and cecum.